• Mashup Score: 0

    In basal cell carcinoma, the most common type of skin cancer accounting for 80% of all non-melanoma skin cancers, one of the leading options for cases that fall into this category is targeted treatment with Hedgehog pathway inhibitors.

    Tweet Tweets with this article
    • In basal cell #carcinoma, the most common type of #skincancer accounting for 80% of all non-#melanoma skin cancers, one of the leading options for cases that fall into this category is targeted treatment with #Hedgehog pathway #inhibitors. https://t.co/6u3PIst5JM

  • Mashup Score: 3
    Wolters Kluwer Health - 2 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…

    Tweet Tweets with this article
    • Great Debates: EGFR Inhibitors or VEGF Inhibitors for Left-Sided #ColorectalCancer: https://t.co/5PcXGHw14I #MedicalDebates #MedTwitter #Inhibitors https://t.co/EuZiNHExkq

  • Mashup Score: 1
    Wolters Kluwer Health - 2 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…

    Tweet Tweets with this article
    • Great Debates: EGFR Inhibitors or VEGF Inhibitors for Left-Sided #ColorectalCancer: https://t.co/qmoUxtMsbk #MedicalDebates #MedTwitter #Inhibitors https://t.co/REjcrMOqkZ

  • Mashup Score: 0
    Wolters Kluwer Health - 2 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…

    Tweet Tweets with this article
    • Great Debates: EGFR Inhibitors or VEGF Inhibitors for Left-Sided #ColorectalCancer: https://t.co/qmoUxu4Bps #MedicalDebates #MedTwitter #Inhibitors https://t.co/GPYIPtLIqH